HIFU shows promise for treating prostate cancer

EDAP TMS has announced the results of a study using High Intensity Focused Ultrasound for localised prostate cancer which demonstrates promising oncologic outcomes with low side effects.

The prospective, independent, multi-centre study conducted by the French Urological Association (AFU) was designed to evaluate HIFU hemiablation (treatment of the half of the prostate where the tumour is located, sparing the rest of the gland) as a primary treatment for localised, unilateral prostate cancer. 

In the study, 111 patients received focal hemiablation using HIFU with the medical device called Ablatherm HIFU at 10 different clinical institutions. Control biopsies were performed one year following treatment, with 95% of subjects showing absence of clinically significant cancer on the treated side. The study also showed very low side effects with continence preserved in 97% of patients at one year and erectile function preserved in 78% of patients. There was no significant decrease in Quality of Life score observed at 12 months, and the rate of radical treatment free survival at two years was 89%, meaning that only 11% of patients underwent surgery or radiotherapy. Pascal Rischmann, lead author on the study, said: "This study supported by the French Association of Urology builds upon the interest in focal therapy and demonstrates its role in the management of prostate cancer based on quality of life preservation and efficacy. I have long thought HIFU was an ideal ablation modality for focal therapy and this is substantiated by the study results." The results of the study are published in the journal European Urology.

 

 

Other news

Upcoming Events

QIST 2017

The Marriott Hotel Gosforth Newcastle
17th - 18th October

MEDICA

Düsseldorf
13 - 16 November 2017

IDSc CONFERENCE 2016

The Hilton, Blackpool
27th - 29th November

Latest Issue

Clinical Services Journal

Clinical Services Journal

Sep 2017

Being confident that your wipes work

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Aug 2017

Technology with the vision to make surgery better

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.